The largest database of trusted experimental protocols

Histostainer

Manufactured by Nichirei Biosciences
Sourced in Japan

The HISTOSTAINER is an automated tissue staining system designed for consistent and efficient staining of histological samples. It performs a range of staining protocols, including hematoxylin and eosin (H&E) staining, immunohistochemistry, and special stains. The HISTOSTAINER ensures standardized and reproducible staining results, making it a valuable tool for research, clinical diagnostics, and pathology laboratories.

Automatically generated - may contain errors

9 protocols using histostainer

1

Immunohistochemical Staining of Paraffin Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sections of paraffin blocks were used for immunohistochemical staining with an automatic immunohistochemical stainer, the HISTOSTAINER (Nichirei Bioscience, Tokyo, Japan). Briefly, the sections were deparaffinized, rehydrated, and boiled at 96°C for 40 minutes in TE solution (pH 9.0) for antigen retrieval. Endogenous peroxidase activity was blocked by incubation for 5 minutes in a 3% hydrogen peroxide solution. Next, the sections were incubated with a rabbit anti-BSND polyclonal antibody (1:1000; Sigma–Aldrich, St. Louis, MO), a rabbit anti-ATP6V1G3 polyclonal antibody (1:2000; Sigma–Aldrich), or a rabbit anti-FBN3 polyclonal antibody (1:100; Sigma–Aldrich) for 30 minutes at room temperature. After washing, the sections were incubated for 30 minutes at room temperature with an amino acid polymer conjugated with goat antirabbit IgG and horseradish peroxidase (Histofine Simple Stain MAX-PO Kit; Nichirei, Tokyo, Japan). The antigen–antibody complex was visualized with 3,3′-diaminobenzidine tetrahydrochloride, and the sections were counterstained with hematoxylin. The staining intensity for BSND and ATP6V1G3 were graded for each specimen as follows: negative, weakly positive, or strongly positive. Additionally, proportion of positive cells for each specimen in the immunostaining was grouped into 3 categories as follows: none (<1%), partial (1%–90%), and diffuse (≥90%).
+ Open protocol
+ Expand
2

Multiplex RT-PCR Fusion Variant Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pathological diagnosis was confirmed by H.O., A.N., and/or T.Y. based on morphological observations and existing RT–PCR and/or FISH analysis. The clinical samples other than tumor 4 used in this study had already been identified for fusion variants by existing RT–PCR. Furthermore, the multiplex RT–PCR and sequencing analysis were performed as blind for experimenter, and the result was collated with that of existing method. Immunostaining was performed using HISTOSTAINER (NICHIREI BIOSCIENCES, Tokyo, Japan) or the BOND-III automated stainer (Leica Biosystems, Nussloch, Germany). Detailed information about the antibodies used in this study is listed in Supplementary Table S1.
+ Open protocol
+ Expand
3

Immunohistochemical Analysis of Skin Ulcers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Skin ulcer tissue samples were obtained from three patients (burn ulcer, postsurgical ulcer, and stasis ulcer). Informed consent was obtained from each patient. Paraffin-embedded tissues were sectioned at a thickness of 3 μm and stained for PXR using Histofine Simple Stain Max-PO (Multi) (Nichirei Biosciences Inc., Tokyo, Japan) and the automated staining device Histostainer (Nichirei Biosciences Inc.). Hematoxylin was used for the counterstaining of nuclei. Images were captured using a virtual slide system and OlyVIA software (Olympus, Tokyo, Japan). This study was approved by the Institutional Ethics Committee of Kyushu University Hospital (Approval ID: 30-363), and conducted in accordance with the Declaration of Helsinki. Written informed consent was received from the patients prior to their inclusion in the study.
+ Open protocol
+ Expand
4

Immunohistochemical Staining of CLCA2 in Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sections of TMA blocks were used for immunohistochemical staining with an automatic immunohistochemical stainer, the HISTOSTAINER (Nichirei Bioscience, Tokyo, Japan). To explain in greater detail, the sections were deparaffinized, rehydrated, and boiled at 96°C for 40 min in TE solution (pH 9.0) for antigen retrieval. Endogenous peroxidase activity was blocked by incubation for 5 min in a 3% hydrogen peroxide solution. Next, the sections were incubated with a rabbit anti-CLCA2 polyclonal antibody (Sigma, St. Louis, MO, USA) at a dilution of 1 : 1,000 for 30 min at room temperature (RT). After washing, the sections were incubated for 30 min at RT with an amino acid polymer conjugated with goat anti-rabbit IgG and horseradish peroxidase (Histofine Simple Stain MAX-PO kit, Nichirei, Tokyo, Japan). The antigen-antibody complex was visualized with 3,3′-diaminobenzidine tetrahydrochloride, and the sections were counterstained with hematoxylin. Esophageal stratified squamous epithelium and gastric foveolar epithelium were used as positive control and negative control, respectively, for the CLCA2 immunohistochemistry (see Supplementary Figure S1 in Supplementary Material available online at http://dx.doi.org/10.1155/2014/619273), based on previous reports [24 (link)].
+ Open protocol
+ Expand
5

Immunohistochemical Analysis of Tissue Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
Deparaffinized and hydrated 3 micron-thick sections were pretreated according to the commercial recommendations. A high-temperature unmasking technique was performed by the autoclave at 121°C for 15 min in 0.01 M sodium citrate buffer solution (pH 6.0), and some sections were digested with proteinase K (DAKO, Glostrup, Denmark). As shown in Table 1, COL4 (DAKO, Glostrup, Denmark), K19 (Leica Biosystems, Newcastle, UK), DSG1 (PROGEN, Heidelberg, Germany) and Ki-67 (Leica Biosystems, Newcastle, UK) were used as primary antibodies. All antibodies were incubated at 4°C for 24 h. Nichirei MAX-PO Multi (Nichirei, Tokyo, Japan) was used as secondary antibody. Sections were incubated at room temperature using HISTOSTAINER (Nichirei) for 30 min. After visualization with 3-3'-diaminobenzidine tetrahydrochloride (Dako, Glostrup, Denmark), sections were counterstained with hematoxylin. Negative control slides were processed with phosphate buffered saline instead of primary antibodies.
+ Open protocol
+ Expand
6

Immunohistochemical Analysis of TP53 Expression in Gastric Carcinoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
TP53 protein expression in gastric carcinoma with TP53 missense mutations was evaluated via immunohistochemistry. Tissue FFPE blocks were cut into 4-µm-thick sections. After deparaffinization, immunostaining was performed using an automatic immunohistochemical stainer, the HISTOSTAINER (Nichirei Bioscience, Tokyo, Japan) with Histofine Simple Stain MAX PO (Nichirei) as previously described [42 (link)]. A primary antibody for TP53 (Mouse monoclonal, clone DO-7; Dako, Glostrup, Denmark) was used, and 3,3′-diaminobenzidine (DAB) (Dako) was used as a chromogen. Nuclear counterstaining was performed using hematoxylin. The staining signal was visualized using a Leica DMD 108 microscope (Leica Biosystems, Wetzlar, Germany). Representative photomicrographs were captured using the same microscope.
+ Open protocol
+ Expand
7

Immunohistochemical Profiling of Bladder Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor and/or normal tissue specimens from the patients were obtained at TURBT and/or cystectomy. Tissue microarrays were constructed by harvesting 2 mm tissue cores (or 1mm tissue cores when only small samples were available) from FFPE tumor or normal tissue samples of BCG-resistant patients. For IHC, the microarray sections (4-μm-thick) were mounted on glass slides, heat-treated for 15 min, and then incubated with rabbit mAb against PD-L1 (clone E1L3N; Cell Signaling Technology, Danvers, MA), mouse mAb against PD-L2 (clone MIH18; eBioscience, San Diego, CA), rabbit polyclonal Ab against CD8 (Abcam, Tokyo, Japan), rabbit mAb against FOXP3 (clone SP97; Abcam), or rabbit polyclonal Ab against CD69 (Abcam) for 30 min, followed by their corresponding secondary antibodies for 30 minutes, with the use of HISTOSTAINER (Nichirei Biosciences Inc., Tokyo, Japan). This automated system used 3, 3′ diaminobenzidine (DAB) as the chromogen (Nichirei Biosciences Inc.). FFPE tissue samples from recurrence-free patients were also sectioned and stained with anti-PD-L1 antibody (E1L3N). PD-L1- or PD-L2-overexpressing HEK293 cells (ATCC, Manassas, VA) that were transiently transfected with PD-L1 or PD-L2 cDNA were prepared as a positive control for staining of each antibody (Supplementary Figure 1).
+ Open protocol
+ Expand
8

Molecular Profiling of Astrocytic Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The status of IDH1 (R132H), p53, and ATRX was analyzed by immunohistochemistry using the automated immunostaining processor Histostainer (Nichirei Biosciences, Tokyo, Japan). The antibodies used include anti-IDH1 (R132H) (DIA-H09; Dianova, Hamburg, Germany), anti-p53 (DO-7; Nichirei), and anti-ATRX (HPA001906; Sigma-Aldrich, St. Louis, MO). We judged the tumor as p53-positive when >50% of the tumor nuclei displayed the strong immunoreactivity of p53, which could be corroborated by the loss of immunoreactivity for ATRX (inactivating mutation) and 1p/19q-nondeletion in the astrocytic tumors [19 (link), 20 (link), 22 (link)]. The status of chromosomes 1p and 19q was examined by fluorescence in situ hybridization (FISH) with 1p36 and 19q13 probes (Vysis; Abbott Molecular, Abbott Park, IL), and signal ratios were calculated according to the previous report [23 (link)]. Two reported hot spot mutations (C228T and C250T) in a TERT promoter region were analyzed by Sanger sequencing. The hotspot mutations at codon 132 of IDH1 and codon 172 of IDH2 were also screened by Sanger sequencing if the cases did not show immunoreactivity for mutated IDH1 (R132H) [24 (link), 25 (link)].
+ Open protocol
+ Expand
9

Histological and Immunostaining Analysis of Kidneys

Check if the same lab product or an alternative is used in the 5 most similar protocols
Kidneys were immediately fixed in a 10% neutral buffered formalin or periodate-lysine-paraformaldehyde (PLP) solution. Deparaffinized sections were stained with hematoxylin and eosin (HE)
for morphological observations. PLP-fixed deparaffinized tissue sections were immunostained with mouse monoclonal antibodies specific for CD68 (clone ED1, IgG1, 1:500, AbD Serotec, Oxford,
UK), CD163 (clone ED2, IgG1, 1:300, AbD Serotec), MHC class II (clone OX6, IgG1, 1:1,000, AbD Serotec), CD4 (clone W3/25, IgG1, 1:2,000, AbD Serotec), CD8 (clone OX-8, IgG1, 1:200, AbD
Serotec) and CD79α (clone HM57, IgG1κ, 1:5, Nichirei Bioscience Inc. Tokyo, Japan) using Histostainer (Nichirei Bioscience Inc.). Briefly, sections were incubated with 5% skimmed milk for 10
min, followed by 1 hr incubation with the primary antibody. After treatment with 3% H2O2 for 15 min, horseradish peroxidase-conjugated secondary antibody (Histofine
Simple Stain MAX PO®; Nichirei Bioscience Inc.) was applied for 30 min. Positive reactions were visualized with 3, 3′-diaminobezidine tetrahydrochloride (DAB substrate kit,
Nichirei Bioscience Inc.), and the sections were lightly counterstained with hematoxylin. For negative controls, tissue sections were treated with non-immunized mouse serum instead of the
primary antibody.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!